Disease Intelligence Center · Pandemic I
Hypothyroidism & Hashimoto's Thyroiditis
Primary hypothyroidism is most often autoimmune (Hashimoto's thyroiditis). It is diagnosed by TSH with free T4, and anti-TPO antibodies identify the autoimmune form. Iodine status, selenium, iron, pregnancy and certain medications all modify thyroid function.
Domain weighting
Organizational emphasisiWeightings describe where this framework directs attention for this condition. They are not a measure of how much any factor caused an individual case.
Root-cause chain
Each link carries its own evidence grade- Thyroid autoimmunity (anti-TPO)→Progressive loss of thyroid hormone outputIA
Lymphocytic infiltration destroys thyroid follicles; anti-TPO positivity predicts progression to overt hypothyroidism (Whickham survey).
Relationship: Established causal
- Iodine deficiency or excess→Altered thyroid hormone synthesisNA
Iodine is required for T4/T3 synthesis; both deficiency and excess can trigger hypothyroidism in susceptible people.
Relationship: Established causal
- Perchlorate and other thyroid-active chemicals→Reduced iodide uptakeTC
Perchlorate competitively inhibits the sodium-iodide symporter; NHANES links urinary perchlorate with TSH in low-iodine women. Detection is not proof of effect.
Relationship: Exposure signal
- Hypothyroidism→Raised LDL and weight gainBA
Reduced LDL-receptor expression and lower basal metabolic rate; corrected by levothyroxine.
Relationship: Established causal
iDetection of an exposure does not establish that it caused a disease. This platform separates exposure, association, plausible mechanism, clinical evidence and demonstrated causation.
Fifth Estate considerations
Microbial ecologyInfection triggers for thyroid autoimmunity remain hypotheses; no antimicrobial treatment is indicated for Hashimoto's.
Go deeper
TOBIN Intelligence LibraryThe full evidence review for Hypothyroidism & Hashimoto's Thyroiditis: each mechanism by domain, what is established versus uncertain, related pandemics, relevant labs and how they move your scores.
Open the Hypothyroidism & Hashimoto's Thyroiditis evidence reviewProtocol Fusion Engine
Six lanes · evidence grade and regulatory status on every entryConventional
Standard of care for overt hypothyroidism (ATA guideline).
Caution: Start low in older adults and heart disease; over-replacement raises atrial fibrillation and bone-loss risk.
Functional
Co-existing deficiencies are common and treatable.
Caution: Treat measured deficiencies only.
Integrative
Improves fatigue and cardiometabolic risk; does not replace hormone therapy.
Caution: Adapt to fatigue level.
Orthomolecular
Trials show lower anti-TPO titers; effect on clinical outcomes is uncertain.
Caution: Upper limit 400 µg/day; excess linked to type 2 diabetes risk.
Traditional
Supports adequate iodine and micronutrients.
Caution: Avoid kelp/iodine megadoses.
Energy / Physical
Energy medicine on Tayapulse →Small trials only; not a substitute for levothyroxine.
Caution: Must not be presented as a treatment for hypothyroidism.
iLanes are presented side by side so the difference in evidence strength is visible. Nothing here is a prescription, and interactions must be reviewed with your clinician and pharmacist.
iEnergy and physical modalities in this lane are explored further with Tayapulse. Evidence grade and regulatory status still apply: these are adjuncts used only where indicated, never cures or replacements for guideline care.
Diagnostics to consider
- · TSH with free T4
- · Anti-TPO antibodies
- · Lipid panel
- · Ferritin and B12 (common co-deficiencies)
- · Pregnancy status — targets differ in pregnancy
Monitoring
- · TSH 6–8 weeks after any dose change
- · TSH every 6–12 months once stable
- · Symptom and weight trend
- · TOBIN score change over time
Prevention emphasis
- · Adequate, not excessive, iodine
- · Avoid unnecessary high-dose biotin before thyroid tests (assay interference)
- · Separate levothyroxine from calcium, iron and coffee by 4 hours / 30–60 minutes